Login
$GERN
$1.15 +$0.00 (0.0%) Close

$GERN 4 SEC Filings

Filed On Filing
01 Oct 2026 Form 4: Spiegel Robert J., Director

Received 6,351 shares as a grant or award ($7.81K)

01 Jul 2026 Form 4: Spiegel Robert J., Director

Received 6,103 shares as a grant or award ($7.81K)

26 May 2026 Form 4: Spiegel Robert J., Director

Granted 220,000 Stock Option (right to buy)

26 May 2026 Form 4: O'Farrell Elizabeth G., Director

Granted 220,000 Stock Option (right to buy)

26 May 2026 Form 4: Molineaux Susan, Director

Granted 220,000 Stock Option (right to buy)

26 May 2026 Form 4: McDonald John F, Director

Granted 220,000 Stock Option (right to buy)

26 May 2026 Form 4: Bir Dawn Carter, Director

Granted 220,000 Stock Option (right to buy)

14 Apr 2026 Form 4: Williams Timothy, EVP and Chief Legal Officer

Granted 2,500,000 Stock Option (Right to Buy)

01 Apr 2026 Form 4: Spiegel Robert J., Director

Received 5,243 shares as a grant or award ($7.81K)

26 Mar 2026 Form 4: Chinoporos Constantine, Director

Granted 270,000 Stock Option (Right to Buy)

26 Mar 2026 Form 4: Andrews Patricia S, Director

Granted 270,000 Stock Option (Right to Buy)

19 Feb 2026 Form 4: Eid Joseph, EVP, R&D; Chief Medical Office

Granted 2,220,000 Stock Option (Right to Buy)

19 Feb 2026 Form 4: Robertson Michelle, EVP, CHIEF FINANCIAL OFFICER

Granted 1,660,000 Stock Option (Right to Buy) · Received 27,500 shares by exercise or conversion · Sold 9,855 shares ($19.1K)

05 Jan 2026 Form 4: Spiegel Robert J., Director

Received 5,918 shares as a grant or award ($7.81K)

20 Oct 2025 Form 4: ElNawawi Ahmed, EVP, Chief Commercial Officer

Granted 3,000,000 Stock Option (right to buy)

01 Oct 2025 Form 4: Spiegel Robert J., Director

Received 5,702 shares as a grant or award ($7.81K)

08 Aug 2025 Form 4: Semerjian Harout, Director

Granted 11,000,000 Stock Option (right to buy)

01 Jul 2025 Form 4: Spiegel Robert J., Director

Received 5,540 shares as a grant or award ($7.81K)

22 May 2025 Form 4: Aggarwal Gaurav, Director

Granted 180,000 Stock Option (right to buy)

22 May 2025 Form 4: Bir Dawn Carter, Director

Granted 180,000 Stock Option (right to buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support